NYU pain research center receives $4.5M NIH grant to study chemotherapy-related pain

On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center

Last summer, Anirban Maitra, a pathologist specializing in pancreatic cancer, joined the NYU Langone Health Laura and Isaac Perlmutter Cancer Center to co-lead its Gastrointestinal Cancer Center.

Oral cancer pain and opioid tolerance share underlying process, study finds

Epidermal growth factor receptor signaling in the tissue around oral cancers both increases nerve sensitivity and makes opioids less effective, according to a study conducted by researchers at NYU, MD Anderson, and Loma Linda University. The finding points to a shared mechanism underlying both oral cancer pain and opioid tolerance, and a possible new treatment strategy for both.

February 06, 2026

Vol.52 No.05

Clinical Roundup

Alliance launches trial to study exercise in cancer patients

The Alliance for Clinical Trials in Oncology has launched a new clinical trial seeking to evaluate the feasibility of delivering a structured exercise program entirely through telehealth for patients with cancer receiving chemotherapy with the ultimate goal of reducing fatigue and disability.

November 14, 2025

Vol.51 No.42

Clinical Roundup

Researchers develop technique to track chemotherapy drug inside cells

Scientists face limitations in determining the results of drug effectiveness, as well as ensuring even distribution among all cancer cells because of the highly compact nature of tumors. Researchers are working to change that by giving chemotherapy drugs a kind of chemical “signal” to track them inside cells.

October 31, 2025

Vol.51 No.40